Despite all of their promise, newer medicines, especially those based on advanced technologies, have been met with unprecedented challenges in scaling up manufacturing, quality control and commercial launch.
Hear how developers have approached different aspects of the manufacturing process to bring new and innovative treatments to patients.
Speakers:
C. Greg Guyer, Ph.D., chief technical officer and executive vice president of global manufacturing and technical operations, BioMarin
Sierk Poetting, Ph.D., chief operating officer, BioNTech
Matthew Herper, senior writer, editorial director of events, STAT (moderator)
Click here to find additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.